- Veri Medtech (VRHI, Financial) has announced the relaunch of its healthcare technology platform, DosePop.com.
- The platform connects patients with physicians to manage health issues like weight loss and hair loss.
- CEO Sam Adetunji emphasizes the platform's role in empowering individuals to take charge of their well-being.
Veri Medtech (VRHI), a leader in healthcare technology, has officially relaunched its innovative platform, DosePop.com, on May 5, 2025. According to CEO Sam Adetunji, DosePop.com acts as a crucial connector between patients and physicians, aimed at enabling individuals to manage various aspects of their health, from weight loss to hair loss treatments.
DosePop.com, a wholly-owned subsidiary of the publicly-traded company Veri Medtech, offers a comprehensive healthcare platform for both mental and physical health. The platform provides science-backed treatments administered by licensed professionals, addressing issues ranging from weight loss to anti-aging.
Veri Medtech Holdings (VRHI, Financial) is a publicly-traded company that focuses on telehealth, alternative medicine, and personalized diagnostics. It leverages advanced digital systems to make healthcare more accessible and aims to drive growth through strategic acquisitions and innovations in wellness science.
For more information about Veri Medtech and its services, please visit DosePop.com and VeriMedTech.com.
